About the Company
biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated dna , both in circulating tumor cells (ctcs) and in plasma (cell free circulating tumor dna). our mission is to improve outcomes for cancer patients by advancing oncology diagnostics. we utilize patented and innovative technologies to deliver clinically relevant oncology diagnostics to physicians by providing advanced prognostic and predictive assessments for guiding the course of treating patients. additionally, we offer services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies, and clinical trial support. our strategic focus is to promote our unique targeted selector™ technology to the oncology community. our target selector technology has demonstrated that it can consistently capture extremely rare cells which may be present in only 1 of every 50-100 billion blood cells. examples of these rare cells ar
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BIOC News
Biocept (BIOC) Stock Soaring After Expanding Blood-Based Test Menu
Separately, TheStreet Ratings team rates BIOCEPT INC as a Sell with a ratings score of E+. TheStreet Ratings Team has this to say about their recommendation: "We rate BIOCEPT INC (BIOC ...
Biocept (BIOC) Stock Popping on Blue Cross Blue Shield Partnership
TheStreet Ratings has this to say about the recommendation: We rate BIOCEPT INC as a Sell with a ratings score of E+. This is based on several weak investment measures, which should drive this ...
Biocept, Inc. (BIOCQ) Stock Historical Prices & Data - Yahoo Finance
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Biocept, Inc. (BIOCQ)
You could be flying above traffic to the airport in an electric air taxi for the same cost as an Uber (UBER) by 2025, at least according to Joby Aviation (JOBY). Electric Vertical Takeoff and ...
Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket
Biocept, Inc. (NASDAQ: BIOC) fell 14.1% to $0.3010 in pre-market trading. Biocept recently reported 2022 loss of $1.89 per share. SAB Biotherapeutics, Inc. (NASDAQ: SABS) fell 13.4% to $0.94 in ...
Biocept (NASDAQ: BIOC)
Biocept, Inc. is an oncology laboratory service company, which engages in the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells.
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Voyager Therapeutics, Inc. (NASDAQ: VYGR) fell 10.6% to $12.37. Kingsoft Cloud Holdings Limited (NASDAQ: KC) dropped 10% to $4.2750 following weak quarterly results. Biocept, Inc (NASDAQ ...
Medical Laboratories Stocks Under Scanner -- Great Basin Scientific, Biocept, Quintiles IMS, and OpGen
Visit us today and download your complete report on GBSN for free at: San Diego, California headquartered Biocept Inc.'s stock declined 5.04%, closing the day at $2.26 with a total trading volume ...
ALLR Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response ...
EZGO Technologies Stock (NASDAQ:EZGO), Quotes and News Summary
Here Are Other Stocks Moving In Friday's Mid-Day Session Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for ...
MCET MultiCell Technologies, Inc.
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional ...
Etsy Inc.
1 Day ETSY -0.46% DJIA 0.67% S&P 500 0.87% Retail/Wholesale 0.37% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the ...
Loading the latest forecasts...